The FDA cleared an Apple Watch monitoring tool that was developed through research conducted at the University of Oxford.
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA cleared an Apple Watch monitoring tool that was developed through research conducted at the University of Oxford.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Apple Watch
mobile application developed by Apple
-
University of Oxford
collegiate research university in Oxford, England
- Mathews Mtumbuka's career journey includes studying engineering at MUBAS, working for Airtel in Malawi, and later gaining experience with Shell Oil in Scotland before pursuing a PhD at the University of Oxford.
- A study focused on high blood pressure in England was conducted using data from the Our Future Health programme.
Related events
- Quest Diagnostics is conducting advanced biomarker testing in partnership with Apple Watch in the U.S.
- Apple is testing new Apple Watch models, with previews provided by Gurman.
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- The FDA received information on June 27, 2025, regarding regulatory approval to streamline patient monitoring for a product involving Bristol-Myers Squibb.
- Oura and Apple Watch are being used to track sleep data for health analysis.